SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.11-2.6%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: zeta1961 who wrote (21351)9/19/2006 4:17:08 PM
From: Mike McFarland  Read Replies (1) of 52153
 
It might be too simple, but it seems as though
a good Pharma strategy is to get them when they're
down and collect a dividend while they recover.

So you own Merck and Pfizer--not Novartis and GSK.

All I know is the second most successful investor
in my office has owned MO a long time, and that
buying dips and collecting the fat dividend has
paid off really well--over long periods of time.
Otherwise, I haven't given it much thought.

You do stumble on Novartis a lot when you look
at smallish biotech companies, that's for sure.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News